Evaluation of some biochemical parameters in fluid cysts and serum in different types of ovarian cysts





Research Article

American Journal of BioMedicine
Volume 10, Issue 3, August 11 2022, Pages 111-127 | http://dx.doi.org/10.18081/2333-5106/2022.10/111

Estabraq AR. Al-Wasiti 1*, Maysoon Mahmood Hussein 2, Sarab Hilal Abdulhussain 3 

Author Affiliations
*Correspondence author e-mail: dr.estabrag.alwasiti@colmed-alnahrain.edu.iq : 1 Department of Clinical Biochemistry, College of Medicine, AL-Nahrain University Baghdad /Iraq, 2Department of Clinical Biochemistry, Ministry of Health and environment of Iraq, Baghdad, Iraq, 3 Ministry of Health and environment of Iraq, Al-yarmuk teaching hospital, Iraq.

Received April 30 2022   Revised  June 21 2022   Accepted July 20 2022   Published August 11 2022

 

Abstract

Despite their high prevalence in women of different age, the aetiopathogenesis of ovarian cysts (O.C.) unknown. This study is aimed to evaluate the total protein bound hexose (TPHex), total protein (TP), total carbohydrate (TCHO), lactate dehydrogenase (LDH) and iron (Fe+2) in fluid of function, benign, and malignant ovarian cyst. Also demonstrate the change in serum PHex and LDH (of patients with ovarian cyst) and their roles in diagnosis of patients with malignant ovarian cyst. A cross sectional study included sixty- seven women with ovarian cyst (ten of them with functional cyst, thirty two with benign neoplastic cyst and twenty five of them with malignant  ovarian cyst). Twenty-six healthy women as a control group also participated in the current study. The age of subjects ranged from (twelve to sixty-seven) years. Different biochemical parameters were carried out in ovarian cyst fluid (O.C.F.) and in serum include (TPHex), total protein (TP), total carbohydrate (TCHO), lactate dehydrogenase (LDH) and iron (Fe+2). In the present study, a comparative study of biochemical parameters revealed that a significant increase in fluid (TPHex), total protein (TP), total carbohydrate (TCHO), lactate dehydrogenase (LDH) and iron (Fe+2) levels in malignant and benign ovarian cyst when compared with functional ovarian cyst, also there is a significant increase in malignant (O.C.F.) compared with benign (O.C.F.). In the serum, our study shows a highly significant elevation in PHex and LDL enzyme in patients with malignant and benign ovarian cysts compared with serum PHex and LDL of normal healthy control, while there is insignificant difference in serum PHex level in patients with malignant ovarian cyst compared with that of patients with benign ovarian cyst. There is no correlation between level of PHex in serum and fluid, while There is a direct correlation between LDH level in serum and fluid cyst. In conclusion, both fluid and serum LDH level can considered as a tumour marker for malignant ovarian cyst also there is a direct correlation between serum and fluid. Fluid TCHO level have a useful role in diagnosis of benign and malignant ovarian cyst. Iron is useful in differentiating endometrioid cyst from other types of cysts, but it is not useful in differentiating benign from malignant ovarian cyst.

Keywords: Ovarian cysts; PHex and LDL; Fluid TCHO

Copyright © 2022 Estabraq AR. Al-Wasiti et al. This article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to citeReferencesDownload citationStatistics
The citation data is computed by the following citation measuring services:

RIS
Hidden content
EndNote
Hidden content
Mendeley
Hidden content
BibTeX
Hidden content
APA
Hidden content
MLA
Hidden content
HARVARD
Hidden content
VANCOUVER
Hidden content

  1. Albers CE, Ranjit E, Sapra A, Bhandari P, Wasey W. Clinician beware, giant ovarian cysts are elusive and rare. Cureus. 2020 Jan 23;12(1).
  2. Awais GM. Dysgerminoma and serum lactic dehydrogenase levels. Obstetrics and Gynecology. 1983 Jan 1;61(1):99-101.
  3. Bose KS, Gokhale PV, Dwivedi S, Singh M. Quantitative evaluation and correlation of serum glycoconjugates: Protein bound hexoses, sialic acid and fucose in leukoplakia, oral sub mucous fibrosis and oral cancer. Journal of natural science, biology, and medicine. 2013 Jan;4(1):122.
  4. Boss EA, Massuger LF, Thomas CM, Geurts‐Moespot A, Boonstra H, Sweep CG. Vascular endothelial growth factor in ovarian cyst fluid. Cancer. 2001 Jan 15;91(2):371-7.
  5. Burd JF, Usategui-Gomez M. A colorimetric assay for serum lactate dehydrogenase. Clinica Chimica Acta. 1973 Jul 14;46(3):223-7.
  6. Ceriotti F, Ceriotti G. Improved direct specific determination of serum iron and total iron-binding capacity. Clinical chemistry. 1980 Feb 1;26(2):327-31.
  7. Cylwik B, Chrostek L, Szmitkowski M. Diagnostic value of total and lipid-bound sialic acid in malignancies. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego. 2005 Aug 1;19(110):237-41.
  8. Demirci H, Erdamar H, Bukan N, Dikmen K, Karakoc A, Arslan M. Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid. 2007: 1517-1522.
  9. Doumas BT, Bayse DD, Borner K, Carter RJ, Elevitch F, Garber CC, Graby RA, Hause LL, Mather A, Peters Jr T, Rand RN. A candidate reference method for determination of total protein in serum. II. Test for transferability. Clinical chemistry. 1981 Oct 1;27(10):1651-4.
  10. Fujii S, Konishi I, Suzuki A, Okamura H, Okazaki T, Mori T. Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma. Gynecologic oncology. 1985 Sep 1;22(1):65-72.
  11. Gaunitz S, Nagy G, Pohl NL, Novotny MV. Recent advances in the analysis of complex glycoproteins. Analytical chemistry. 2017 Jan 3;89(1):389-413.
  12. Guo SW, Ding D, Shen M, Liu X. Dating endometriotic ovarian cysts based on the content of cyst fluid and its potential clinical implications. Reproductive Sciences. 2015 Jul;22(7):873-83.
  13. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature. 2008 Apr;452(7187):571-9.
  14. Hewitt BR. Spectrophotometric determination of total carbohydrate. Nature. 1958 Jul;182(4630):246-7.
  15. Iizuka M, Igarashi M, Abe Y, Ibuki Y, Koyasu Y, Ikuma K. Chemical assay of iron in ovarian cysts: a new diagnostic method to evaluate endometriotic cysts. Gynecologic and obstetric investigation. 1998;46(1):58-60.
  16. Khomei Y, Kunio O, Toshio Y, Hajime W, Shun H, Seiichi O. Biochemical characterization of glycoprotein components in human ovarian cyst fluids by lectins. International Journal of Biochemistry. 1990 Jan 1;22(6):659-63.
  17. Kloppel TM, Morré DJ. Characteristics of transplantable tumors induced in the rat by N-2-fluorenylacetamide: elevations in tissue and serum sialic acid. JNCI: Journal of the National Cancer Institute. 1980 Jun 1;64(6):1401-11.
  18. Kori M, Aydin B, Gulfidan G, Beklen H, Kelesoglu N, Caliskan Iscan A, Turanli B, Erzik C, Karademir B, Arga KY. The repertoire of glycan alterations and glycoproteins in human cancers. OMICS: A Journal of Integrative Biology. 2021 Mar 1;25(3):139-68.
  19. Kristjansdottir B, Partheen K, Fung ET, Marcickiewicz J, Yip C, Brännström M, Sundfeldt K. Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers. Clinical proteomics. 2012 Dec;9(1):1-9.
  20. Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. The Lancet. 2019 Mar 23;393(10177):1240-53.
  21. Li AJ. Serum biomarkers for evaluation of an adnexal mass for epithelial carcinoma of the ovary, fallopian tube, or peritoneum.
  22. Li, Andrew John. "Serum biomarkers for evaluation of an adnexal mass for epithelial carcinoma of the ovary, fallopian tube, or peritoneum." (2021).
  23. Mukherjee S, Sundfeldt K, Borrebaeck CA, Jakobsson ME. Comprehending the proteomic landscape of ovarian cancer: A road to the discovery of disease biomarkers. Proteomes. 2021 Jun;9(2):25.
  24. Ott HW, Lindner H, Sarg B, Mueller-Holzner E, Abendstein B, Bergant A, Fessler S, Schwaerzler P, Zeimet A, Marth C, et al: Calgranulins in cystic fluid and serum from patients with ovarian carcinomas. Cancer Res 2003, 63(21):7507–7514
  25. Parker MF, Conslato SS, Chang AS, Taylor RR, Reed ME, Mayer AR. Chemical analysis of adnexal cyst fluid. Gynecologic oncology. 1999 Apr 1;73(1):16-20.
  26. Practice Committee of the American Society for Reproductive Medicine. Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertility and Sterility. 2012 Apr 1;97(4):825-34.
  27. Rimington C. Seromucoid and the bound carbohydrate of the serum proteins. Biochemical Journal. 1940 Jun;34(6):931.
  28. Roett MA, Evans P. Ovarian cancer: an overview. American family physician. 2009 Sep 15;80(6):609-16.
  29. Sand JA, Hyöty MK, Mattila J, Dagorn JC, Nordback IH. Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas. Surgery. 1996 Mar 1;119(3):275-80.
  30. Savant SS, Sriramkumar S, O’Hagan HM. The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer. Cancers. 2018 Jul 30;10(8):251.
  31. Schneider D, Halperin R, Langer R, Bukovsky I, Herman A. Peritoneal fluid lactate dehydrogenase in ovarian cancer. Gynecologic oncology. 1997 Sep 1;66(3):399-404.
  32. Sheeja S, Pothen L. Role of FNAC in the diagnosis of ovarian tumours. Onkologia i Radioterapia. 2021 Mar 15;15(5).
  33. Sheiko MC, Hart WR. Ovarian germinoma (dysgerminoma) with elevated serum lactic dehydrogenase: case report and review of literature. Cancer. 1982 Mar 1;49(5):994-8.
  34. Sundfeldt K, Ivarsson K, Rask K, Haeger M, Hedin L, Brannstrom M: Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Anticancer Res 2001, 21(1A):65–70.
  35. Wilma Delphine Silvia CR, Vasudevan DM, Prabhu KS. Evaluation of serum glycoproteins in oral carcinoma. Indian Journal of Clinical Biochemistry. 2001 Jan;16(1):113-5.
  36. Wu AM. Glycan structures and their recognition roles in the human blood group ABH/Ii, Lea, b, x, y and Sialyl Lea, x active cyst glycoproteins. Glycoconjugate Journal. 2019 Dec;36(6):495-507.
  37. Zhang Z, Wuhrer M, Holst S. Serum sialylation changes in cancer. Glycoconjugate journal. 2018 Apr;35(2):139-60.

1. Access through OpenAthens

2. PDF     XML

For any technique error please contact us.

Downloads: 206

Downloads: 206

PDF            XML

How to cite this article
Al-Wasiti E, Hussein MM, Abdulhussain SH. Evaluation of some biochemical parameters in fluid cysts and serum in different types of ovarian cysts. American Journal of BioMedicine. 2022; 10(3): 111-127. http://dx.doi.org/10.18081/2333-5106/2022.10/111

 

Archives

Article metric